Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 15 of 23
Tagworks Pharmaceuticals
Tagworks Pharmaceuticals
Ysios BioFund III
NL
Active
Sector
Biotech
InvestorYsios Capital Partners
Entry
2023
Hold
3yr
Targed
Targed
BioDiscovery 6
France
Active
Sector
Biotech
InvestorAndera Partners
Entry
2022
Hold
4yr
Telomere Therapeutics
Telomere Therapeutics
Invivo Ventures
Spain
Active
Sector
Biotech
InvestorInvivo Partners
Entry
2020
Hold
6yr
Thabor Therapeutics
Thabor Therapeutics
AFB Fund II
France
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2021
Hold
5yr
Theolytics
Theolytics
Oxford Science Enterprises Balance Sheet
UK
Active
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2017
Hold
9yr
Tizona Therapeutics
Tizona Therapeutics
Abingworth Bioventures VI
US
Active
Sector
Biotech
InvestorAbingworth
Entry
2016
Hold
10yr
TolerogenixX
TolerogenixX
HTGF II
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
TQ Therapeutics
TQ Therapeutics
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
TR1X
TR1X
Neva First
United States
Active
Sector
Biotech
InvestorNeva SGR
Entry
2022
Hold
4yr
Transcripta Bio
Transcripta Bio
BlueYard Capital Fund II
United States
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2020
Hold
6yr
Treefrog
Treefrog
Digital 3
France
Active
Sector
Biotech
InvestorXAnge
Entry
2019
Hold
7yr
TRexBio
TRexBio
SV Life Sciences Fund VI
United States
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2018
Hold
8yr
Tridek-One
Tridek-One
AFB Seed-Fund
France
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2019
Hold
7yr
Triple Bio
Triple Bio
Nucleus Capital II
Netherlands
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2026
Hold
0yr
Trishula Therapeutics
Trishula Therapeutics
Abingworth Bioventures VII
US
Active
Sector
Biotech
InvestorAbingworth
Entry
2020
Hold
6yr
Triumvira Therapeutics
Triumvira Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Twig Bio
Twig Bio
Project A Ventures IV
United Kingdom
Active
Sector
Biotech
InvestorProject A Ventures
Entry
2023
Hold
3yr
Tyris TX
Tyris TX
Columbus Life Sciences Fund III
Spain
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2021
Hold
5yr
Valbiotis
Valbiotis
ACI (Aquitaine Creation Investissement)
France
Active
Sector
Biotech
InvestorAquiti Gestion
Entry
2015
Hold
11yr
Valo Therapeutics
Valo Therapeutics
Indaco BIO
Finland
Active
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2025
Hold
1yr
Van Heron Labs
Van Heron Labs
FoodLabs Fund II
United States
Active
Sector
Biotech
InvestorFoodLabs
Entry
2024
Hold
2yr
Vantage Biosciences
Vantage Biosciences
ALSA Ventures European Biotechnology Fund
UK
Active
Sector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
VascVersa
VascVersa
Co-Fund NI
United Kingdom
Active
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2021
Hold
5yr
Ventus Therapeutics
Ventus Therapeutics
TVM Life Science Ventures
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Verdiva Bio
Verdiva Bio
General Atlantic Growth Equity Fund
United States
Active
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
VEROVACCiNES
VEROVACCiNES
HTGF III
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Violet Therapeutics
Violet Therapeutics
Dementia Discovery Fund 2
United States
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2023
Hold
3yr
Vivalyx
Vivalyx
TechVision Fonds I
Germany
Active
Sector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2024
Hold
2yr
VIVEbiotech
VIVEbiotech
Inveready Biotech II
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2019
Hold
7yr
Vivoryon Therapeutics
Vivoryon Therapeutics
bmp Aktiengesellschaft
Germany
Active
Sector
Biotech
Investorbmp Ventures AG
Entry
1997
Hold
29yr
Wugen
Wugen
Abingworth Bioventures 8
US
Active
Sector
Biotech
InvestorAbingworth
Entry
2021
Hold
5yr
WuXi Biologics
WuXi Biologics
General Atlantic Portfolio
China
Active
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Wuxi XDC
Wuxi XDC
General Atlantic Growth Equity Fund
China
Active
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
X-Therma
X-Therma
LIFTT
United States
Active
Sector
Biotech
InvestorLIFTT
Entry
2024
Hold
2yr
Zedira
Zedira
HTGF I
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2007
Hold
19yr
Zentraxa
Zentraxa
Elbow Beach Capital
UK
Active
Sector
Biotech
InvestorElbow Beach Investments
Entry
2022
Hold
4yr
DiogenX
Omnes Real Tech 1
France
Active
Sector
Biotech
InvestorOmnes Capital
Entry
2020
Hold
6yr
Owners
5
Inato
La Maison NextGen
France
Active
Sector
Biotech
InvestorLa Maison Partners
Entry
2017
Hold
9yr
Owners
5
Insempra
Possible Ventures Fund III
Germany
Active
Sector
Biotech
InvestorPossible Ventures
Entry
2020
Hold
6yr
Owners
5
SciRhom
Wellington Partners Life Sciences
France
Active
Sector
Biotech
InvestorWellington Partners
Entry
2016
Hold
10yr
Owners
5
Abalos Therapeutics
coparion
Germany
Active
Sector
Biotech
Investorcoparion
Entry
2019
Hold
7yr
Owners
4
AnaCardio
Novo Holdings Venture Investments
Sweden
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Owners
4
Biomemory
Sorbonne Venture by Audacia
France
Active
Sector
Biotech
InvestorAudacia
Entry
2024
Hold
2yr
Owners
4
DeepLife
Oscar & Paul Venture Capital Fund I
France
Active
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Owners
4
EVerZom
Cap Innov'Est 2
France
Active
Sector
Biotech
InvestorCapital Grand Est
Entry
2019
Hold
7yr
Owners
4
Exciva
LifeArc Ventures
Belgium
Active
Sector
Biotech
InvestorLifeArc
Entry
2019
Hold
7yr
Owners
4
Phagos
Citizen Capital Fund III
France
Active
Sector
Biotech
InvestorCitizen Capital
Entry
2025
Hold
1yr
Owners
4
SenseUp
Simon Capital Evergreen
Germany
Active
Sector
Biotech
InvestorSimon Capital
Entry
2025
Hold
1yr
Owners
4
Tacalyx
Boehringer Ingelheim Venture Fund
France
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
7yr
Owners
4
Adcytherix
Angelini Ventures
France
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2019
Hold
7yr
Owners
3